Metoprolol

Home
About
Help
History (1)
- Metoprolol
- See All Pages

"Metoprolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.

Descriptor ID	D008790
MeSH Number(s)	D02.033.100.624.698.573 D02.033.755.624.698.573 D02.092.063.624.698.573
Concept/Terms	Metoprolol Metoprolol Betalok Betalok CGP-2175 CGP-2175 CGP 2175 CGP2175 H 93-26 H 93-26 H 93 26 H 9326 Lopressor Lopressor Beloc-Duriles Beloc-Duriles Beloc Duriles BelocDuriles Seloken Seloken Spesicor Spesicor Spesikor Metoprolol Succinate Metoprolol Succinate Succinate, Metoprolol Metoprolol CR-XL CR-XL, Metoprolol Metoprolol CR XL Toprol-XL Toprol-XL Toprol XL ToprolXL Toprol Betaloc Betaloc Betaloc-Astra Betaloc Astra BetalocAstra Metoprolol Tartrate Metoprolol Tartrate Tartrate, Metoprolol

Below are MeSH descriptors whose meaning is more general than "Metoprolol".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Alcohols [D02.033]
Amino Alcohols [D02.033.100]
Propanolamines [D02.033.100.624]
Phenoxypropanolamines [D02.033.100.624.698]
Metoprolol [D02.033.100.624.698.573]
Propanols [D02.033.755]
Propanolamines [D02.033.755.624]
Phenoxypropanolamines [D02.033.755.624.698]
Metoprolol [D02.033.755.624.698.573]
Amines [D02.092]
Amino Alcohols [D02.092.063]
Propanolamines [D02.092.063.624]
Phenoxypropanolamines [D02.092.063.624.698]
Metoprolol [D02.092.063.624.698.573]

Below are MeSH descriptors whose meaning is related to "Metoprolol".

Below are MeSH descriptors whose meaning is more specific than "Metoprolol".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Metoprolol" by people in this website by year, and whether "Metoprolol" was a major or minor topic of these publications.

Bar chart showing 6 publications over 5 distinct years, with a maximum of 2 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	0	1
2007	1	0	1
2009	2	0	2
2014	1	0	1
2020	0	1	1

Below are the most recent publications written about "Metoprolol" by people in Profiles.

Sahu KK, Mishra AK, Doshi A, Martin KB. Heart broken twice: a case of recurrent Takatsubo cardiomyopathy. BMJ Case Rep. 2020 Jan 07; 13(1).

View in: PubMed
Okamoto LE, Gamboa A, Shibao CA, Arnold AC, Choi L, Black BK, Raj SR, Robertson D, Biaggioni I. Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension. Hypertension. 2014 Dec; 64(6):1241-7.

View in: PubMed
Herman M, Donovan J, Tran M, McKenna B, Gore JM, Goldberg RJ, Tighe DA. Use of beta-blockers and effects on heart rate and blood pressure post-acute coronary syndromes: are we on target? Am Heart J. 2009 Sep; 158(3):378-85.

View in: PubMed
McNeely M, Connelly NR. Questionable benefit of perioperative beta-blockade. J Clin Anesth. 2009 May; 21(3):233-4.

View in: PubMed
Phillips RA, Fonseca V, Katholi RE, McGill JB, Messerli FH, Bell DS, Raskin P, Wright JT, Iyengar M, Anderson KM, Lukas MA, Bakris GL. Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study. J Cardiometab Syndr. 2008; 3(4):211-7.

View in: PubMed
Wright JT, Bakris GL, Bell DS, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Holdbrook FK, Lukas MA, Iyengar M. Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial. J Clin Hypertens (Greenwich). 2007 Nov; 9(11):842-9.

View in: PubMed
Messerli FH, Bell DS, Fonseca V, Katholi RE, McGill JB, Phillips RA, Raskin P, Wright JT, Bangalore S, Holdbrook FK, Lukas MA, Anderson KM, Bakris GL. Body weight changes with beta-blocker use: results from GEMINI. Am J Med. 2007 Jul; 120(7):610-5.

View in: PubMed
Go AS, Yang J, Gurwitz JH, Hsu J, Lane K, Platt R. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure. Am J Cardiol. 2007 Aug 15; 100(4):690-6.

View in: PubMed
Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli F, Phillips RA, Raskin P, Wright JT, Waterhouse B, Lukas MA, Anderson KM, Bell DS. Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes. Hypertension. 2005 Dec; 46(6):1309-15.

View in: PubMed
Bakris GL, Bell DS, Fonseca V, Katholi R, McGill J, Phillips R, Raskin P, Wright JT, Iyengar M, Holeslaw T, Anderson KM. The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial. J Diabetes Complications. 2005 Mar-Apr; 19(2):74-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals